000			01572 a2200397 4500
005			20250514222259.0
264		0	_c20050805
008			200508s 0 0 eng d
022			_a0960-894X
024	7		_a10.1016/j.bmcl.2005.02.034 _2doi
040			_aNLM _beng _cNLM
100	1		_aSadashiva, M P
245	0	0	_aEnhancement in antimicrobial activity of 2-(phenyl)-3-(2-butyl-4-chloro-1H-imidazolyl)-5-butylate isoxazolidine. _h[electronic resource]
260			_bBioorganic & medicinal chemistry letters _cApr 2005
300			_a1811-4 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcremonium _xdrug effects
650	0	4	_aAnti-Bacterial Agents _xchemical synthesis
650	0	4	_aAntifungal Agents _xchemical synthesis
650	0	4	_aAspergillus niger _xdrug effects
650	0	4	_aBacillus subtilis _xdrug effects
650	0	4	_aEscherichia coli _xdrug effects
650	0	4	_aFusarium _xdrug effects
650	0	4	_aImidazoles _xchemical synthesis
650	0	4	_aIsomerism
650	0	4	_aIsoxazoles _xchemical synthesis
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aNystatin _xpharmacology
650	0	4	_aStaphylococcus aureus _xdrug effects
650	0	4	_aStructure-Activity Relationship
700	1		_aMallesha, H
700	1		_aKarunakara Murthy, K
700	1		_aRangappa, K S
773	0		_tBioorganic & medicinal chemistry letters _gvol. 15 _gno. 7 _gp. 1811-4
856	4	0	_uhttps://doi.org/10.1016/j.bmcl.2005.02.034 _zAvailable from publisher's website
999			_c15452525 _d15452525